Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 2/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4278718 | 0.80 | CES2 (0.44) | CES2CES1HTR2ATAAR1CYP2D6 | |
| SCHEMBL4269860 | 0.79 | HRH1 (0.41) | CES2CES1HTR2ATAAR1CYP2D6 | |
| SCHEMBL193834 | 0.77 | HTR2A (0.52) | HTR2ATAAR1CYP2D6SRCDPP4 | |
| SCHEMBL6963045 | 0.76 | CYP2D6 (0.44) | CES2CES1HTR2ATAAR1CYP2D6 | |
| SCHEMBL6967520 | 0.76 | TSHR (0.43) | CES2CES1HTR2ATAAR1CYP2D6 | |
| SCHEMBL27400 | 0.76 | LMNA (0.52) | CES2CES1HTR2ATAAR1LMNA | |
| SCHEMBL8845699 | 0.76 | CES2 (0.41) | CES2CES1HTR2ATAAR1CYP2D6 | |
| SCHEMBL8471000 | 0.76 | CES2 (0.46) | CES2CES1HTR2ATAAR1CYP2D6 | |
| SCHEMBL4275218 | 0.74 | GABBR2 (0.46) | HTR2ATAAR1CYP2D6SRCDPP4 | |
| SCHEMBL1155499 | 0.74 | EPHX1 (0.50) | CES2CES1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4271307-A | Bichromophoric benzotriazole-benzoxazole ultraviolet stabilizers and their use in organic compositions | EASTMAN KODAK COMPANY (US) | 1981-06-02 | — | — | US | claimed |
| US-4087426-A | Oxybisberberine and a process for its production | RESEARCH CORPORATION (US) | 1978-05-02 | — | — | US | claimed |
| US-7615660-B2 | Production process of alkoxy-titanium complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-10 | — | — | US | disclosed |
| US-20080306293-A1 | Production Process of Alkoxy-Titanium Complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-12-11 | — | — | US | disclosed |
| EP-1845101-A1 | METHOD FOR PRODUCING ALKOXYTITANIUM COMPLEX | Sumitomo Chemical Company, Limited (JP) | 2007-10-17 | — | — | EP | disclosed |
| EP-0970964-B1 | Method for producing a titanium complex | SUMITOMO CHEMICAL CO (JP) | 2004-04-21 | — | — | EP | disclosed |
| US-6090961-A | Method for producing titanium complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-07-18 | — | — | US | disclosed |
| EP-0970964-A2 | Method for producing titanium complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-01-12 | — | — | EP | disclosed |
| US-4283333-A | α-[4-Oxoazetidin-1-yl]-acetic acid compounds useful as intermediates in preparing 1-oxadethiacephalosporins | SHIONOGI & CO., LTD. (JP) | 1981-08-11 | — | — | US | disclosed |
| US-4087426-A | Oxybisberberine and a process for its production | RESEARCH CORPORATION (US) | 1978-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306293-A1 | Production Process of Alkoxy-Titanium Complex | ABL1, H1-10, ALK | CES2 3184/4885CES1 3119/4885HTR2A 3390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.